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doi:10.1016/j.ejvs.2009.12.009Abstract Introduction: The concept of high-risk patients suggests that such patients will
experience a higher rate of postoperative complications and worse short- and long-term
outcomes, and should therefore benefit from the use of endovascular techniques for aortic
abdominal aneurysm (AAA) repair. The primary goal of this study was to assess the relevance
of the different high-risk criteria, defined by the French health agency Agence Franc¸aise de
Se´curite´ Sanitaire des Produits de Sante´ (AFSSAPS) in a single-centre continuous series.
Secondary goals were to retrospectively compare the incidence of postoperative complications
and short- and long-term survival in three groups of patients.
Materials and methods: Between January 1999 and December 2006, details of all the patients
undergoing elective surgery for AAA in our hospital were recorded into a prospective registry
(nZ 626). Three groups were considered according to the level of risk and type of repair
defined by the AFSSAPS: endovascular aortic aneurysm repair (EVAR) high-risk (HR) (at least
one high-risk factor and EVAR, nZ 138), open HR (at least one high-risk factor and open repair,
nZ 134) and open low-risk (LR) (no high-risk factors and open repair, nZ 344). None of the
low-risk patients were treated using an endovascular approach. The demographics, preopera-
tive risk factors, intra-, postoperative data and short- and long-term survival were compared
between the groups. Interrelations among the set of high-risk criteria for mortality were calcu-
lated using multiple correspondence analysis (MCA).CV, CHU Le Bocage, BP 77908, 21079 Dijon cedex, France. Tel.: þ33 380 293 352; fax: þ33 380 293
u-dijon.fr (E. Steinmetz).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
404 E. Steinmetz et al.Results: The distribution of high-risk criteria was similar in both high-risk groups, except for
age, heart failure and hostile abdomen, which were significantly more frequent in EVAR HR.
Operation time, blood loss and length of stay in an intensive care unit and hospital were signif-
icantly lower in the EVAR HR group. The 30-day mortality and survival rates at 5 years were 5.4
and 59.4% for EVAR HR, 3.7 and 70.4% for open HR and 2.3 and 83.7% for open LR, respectively,
with no significant difference between the three groups for the mortality, but a significant
higher survival at 5 years for the open LR versus both high-risk groups.
Conclusion: The high-risk AFSSAPS criteria were not predictive of postoperative mortality and
should not be used to determine the choice of treatment technique. Other criteria therefore
need to be established to determine whether open or EVAR repair should be used.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Since the first experiences of endovascular aortic aneu-
rysm repair (EVAR) reported by Volodos et al. and Parodi
et al., this treatment option has gained widespread
acceptance and application as an alternative to conven-
tional open repair (OR) of abdominal aortic aneurysm
(AAA).1e4 EVAR was developed to provide a less-invasive
treatment. In France, in 2001, the ad hoc health agency
Agence Franc¸aise de Se´curite´ Sanitaire des Produits de
Sante´ (AFSSAPS), defined different high-risk criteria to
limit the use of EVAR, which was deemed less safe given
the state of knowledge at the time (Table 1).5 EVAR could
only be offered if at least one of the following criteria
were met:
e age 80 years or above;
e non-revascularisable coronary artery disease;
e symptomatic heart failure;
e inoperable aortic valve stenosis;
e left ventricle ejection fraction equal to 40% or less;
e evidenced severe chronic obstructive pulmonary
disease;
e chronic renal insufficiency; and
e hostile abdomen (without specification but including
ascitis and other signs of portal hypertension).
Today, the guidelines are still applied in France,
although some recent publications showed the benefits of
EVAR in a broader population, including younger patients
and in those in good enough health for standard open
surgical repair.6,7 Recently, two major randomised
controlled trials reported a significantly lower perioper-
ative mortality rate for EVAR than for open surgery.8,9 This
has since been emphasised by population-based observa-
tional studies using large databases in the USA.3 The
development of endograft technology has led to a situation
in which EVAR is overtaking open repair, at least in some
countries, and even in low-risk patients.10,11
Objectives
To retrospectively compare lengths of hospital stay, the
incidence of postoperative complications and short- and
long-term survival, and to assess the relevance of the
different AFSSAPS high-risk criteria with regard to the choice
of treatment in a continuous single-centre series of AAA.Materials and methods
A prospective database collecting all of the AAAs treated in
our department of vascular surgery was approved by the
ethics committee of our teaching hospital and initiated in
1999. Using data from this database, we retrospectively
studied a continuous series of consecutive patients who had
undergone elective surgery for AAA from January 1999 to
December 2006 (nZ 626). Three groups were formed,
according to their AFSSAPS risks and type of repair:
 EVAR high-risk (HR): at least one high-risk factor and
endovascular repair (nZ 148);
 open HR: at least one high-risk factor and open repair
(nZ 134); and
 open low-risk (LR): no high-risk factors and open repair
(nZ 344).
Patients who presented with ruptured AAA in the same
period (nZ 65, 15 EVAR and 50 open repairs) were
excluded from the study in order to eliminate bias. In
accordance with the AFSSAPS rules, none of the low-risk
patients received endovascular treatment. The leading
operating surgeon was responsible for selecting EVAR or
open repair for each patient. Patients in the open high-risk
group underwent open repair because of morphological
contraindications for endografting or because of the sur-
geon’s or the patient’s choice. Each patient underwent
a preoperative computerised tomography (CT) scan (cuts
5 mm) and a preoperative multiplanar contrast angiog-
raphy using a catheter with radio-opaque markers to
measure various lengths and to assess pelvic anatomy.
Preoperative angiography has not been used since 2003
because the information provided by the CT scan alone has
been judged sufficient since then.3
All of the patients were treated in the operating room
under general anaesthesia. Open repair was done with
a retroperitoneal approach in all cases. Radiology imaging
was performed with a C-arm fluoroscopic unit with digital
imaging and road-mapping capability (Phillips, the
Netherlands).
Follow-up was organised according to the AFSSAPS
recommendations: contrast-enhanced CT scan and abdom-
inal plain X-ray before hospital discharge and at 6, 12, 18
and 24 months and then yearly. In the case of renal insuf-
ficiency, CT was replaced with magnetic resonance angi-
ography (MRA) or CT without contrast plus a duplex scan.
Table 1 Preoperative demographic data, risk factors, AAA morphology. HR: high-risk; LR: low-risk; ASA: American Society of
Anaesthesiologists score; PAOD: peripheral arterial occlusive disease; TS: trunk stenosis; COPD: chronic occlusive pulmonary
disease; InOp AS: inoperable aortic stenosis; CHD: coronary heart disease; CVA: cerebrovascular accident; TIA: transient
ischaemic attack; AAA: abdominal aortic aneurysm; CIA: common iliac artery. a and b indicate indexed group with no significant
difference when p-value is significant.
Population: N (%) EVAR HR Open HR Open LR p-value df
148 (23.7%) 134 (21.4%) 344 (54.9%)
N (%) N (%) N (%)
a. Cardiovascular risk factors (CVRF):
Gender (Male) 138 (93.2)a 115 (85.8)b 334 (97.1)a <0.01* 2
Age (med) [range] 78a [52e93] 76a [38e89] 71b [33e80] 0.08y 2
Hypertension 105 (70.9) 96 (71.6) 255 (74.1) 0.73z 2
Smoking history 117 (79.1) 100 (74.6) 279 (81.1) 0.17z 2
Dyslipidemia 69 (46.6)a 74 (55.2)b 209 (60.7)b <0.01z 2
Diabetes mellitus 25 (16.9) 17 (12.7) 46 (13.4) 0.35z 2
CVRF (n) 0 6 (4.1) 3 (2.3) 5 (1.5) 0.21z 6
1 31 (20.9) 27 (20.1) 62 (18.0)
2 44 (29.7) 47 (35.1) 99 (28.8)
3 67 (45.3) 57 (42.5) 178 (51.7)
ASA* >2 133 (89.8)a 112 (83.6)a 266 (77.3)b 0.02z 2
b. Past medical history: N (%)
Cancer 35 (23.6)a 20 (14.9)b 41 (11.9)b <0.01z 2
Cardiac disease 100 (67.5)a 67 (50.0)b 142 (41.3)b <0.01z 2
of which myocardial infarction 21 (14.2) 16 (11.9) 60 (17.4) 0.83z 2
PAOD 52 (35.4) 35 (26.1) 94 (27.3) 0.13z 2
Supra aortic TS 43 (29.1)a 38 (28.3)a 63 (18.3)b 0.01z 2
of which CVA/TIA 20 (13.5) 19 (14.2) 37 (10.8) 0.58z 2
c. AFSSAPS high-risk distribution: N (%)
Age >80 54 (36.4) 73 (54.5) e <0.01 1
COPD 36 (24.3) 33 (24.6) e 0.98z 1
Renal insufficiency 41 (27.7) 30 (22.4) e 0.24z 1
Heart failure 43 (29.1) 10 (7.4) e <0.01z 1
InOp AS 3 (2.0) 4 (2.9) e 0.64z 1
Non-revascularizableeCHD 101 (68.2) 6 (4.5) e 0.38z 1
Hostile abdomen 38 (25.6) 8 (5.9) e <0.01z 1
AFSSAPS criteria (n) 1 84 (56.7) 109 (81.3) e <0.01z 3
2 47 (31.7) 21 (15.6) e
3 15 (10.2) 4 (2.9) e
4 2 (1.4) 0 (0.0) e
d. Preoperative morphological data of the AAA (mean  SD)
Aneurysm max diameter (mm) 57.5  8.9 57.8  10.9 56.8  11.4 0.11y 2
Proximal neck length <15 mm (%) e 37 (27.6) 66 (19.2) 0.04z 1
Proximal neck diameter (mm) 24.4  3.2a 22,5  4.1b 22,3  3.9b <0.01y 2
CIA diameter (mm) 15.3  3.9a 17,2  6.2b 16.4  6.3a <0.01y 2
Aneurysmal extension into the CIAs (%) 29 (19.6)a 56 (41.8)b 86 (25.0)a <0.01z 3
* Pearson chi-square test.
y T-test for equality of means test.
z Fisher’s Exact test.
High-risk Criteria Selection in AAA Treatment 405Primary study outcomes focussed on operative mortality
(less than 30 days or during hospital stay if >30 days) and
mortality at 5 years in the three groups. The demographics
(cardiovascular risk factors, past medical history and AFS-
SAPS high-risk), morphological features (proximal neck
length and diameter, aneurysm greatest diameter and
common iliac artery diameter), operative data (operative
time, blood loss, length of stay in the intensive care unit(ICU)), length of hospital stay, postoperative complication
rate, postoperative death rate and long-term survival were
analysed and compared in the three groups.
Statistical analysis
Cumulative event rates were determined with the Kaplane
Meier (KM) survival analysis. The probability difference
Table 2 Operative data; HR: high-risk; LR: low-risk; ICU: intensive care unit. CI: 95% confidence interval. a and b indicate
indexed group with no significant difference when p-value is significant.
Population: N (%) EVAR HR Open HR Open LR p-value df
148 (23.7%) 134 (21.4%) 344 (54.9%)
Operation time (min) Mean  SD 146  67a 193  65b 188  67b <0.01y 2
[CI] [133e160] [183e203] [180e196]
Intraoperative blood loss (ml) Mean  SD 311  259a 1412  1006b 1438  1226b <0.01y 2
[CI] [253e369] [1256e1569] [1295e1581]
Length of ICU stay (days) Mean  SD 1  3a 4  5b 3  5b <0.01y 2
[CI] [0e1] [3.0e5] [3e4]
Length of hospital stay (days) Mean  SD 8  7a 11  9b 10  9b <0.01y 2
[CI] [7e9] [10e13] [9e11]
Postoperative complications (%) 44 (29.7) 50 (37.3) 119 (34.6) 0.27z 2
Mortality rate (%) 8 (5.4) 5 (3.7) 8 (2.3) 0.24z 2
y KruskaleWallis test.
z Fisher’s Exact test.
406 E. Steinmetz et al.between patients from the three groups was compared
using the Log-Rank test.
Results for qualitative covariates were expressed as
percentages. Quantitative variables were expressed as
means  standard deviation (SD) when normally distrib-
uted, but otherwise as median and range. Comparison of
a patient’s characteristics in the three groups was per-
formed using Student’s t-test, variance analysis, Kruskale
Wallis non-parametric tests, Pearson’s chi-square (c2) or
Fischer’s Exact tests when appropriate. A value of p < 0.05
was considered statistically significant. To look for corre-
lations between the different high-risk criteria and the
survival rate after AAA repair, a multivariate method,
named multiple correspondence analysis (MCA) was used.
This analysis makes it possible to visualise the similarities
and/or differences in profile.12 Categories plotted close to
each other are statistically related and are similar with
regard to the pattern of relative frequencies.13
Statistical analyses were performed using commercially
available STATA software version 10.0 (StataCorp, College
Station, TX, USA). MCA was performed with SAS version 8.2
software (SAS Institute Inc., Cary, NC, USA).12
Results
The analysis of the three groups e EVAR HR, open HR and
open LR e are presented in Tables 1e3 and Figs. 1 and 2.
Table 1 shows the demographics, including cardiovascular
risk factors, past medical history and the different AFSSAPS
high-risk criteria. With regard to cardiovascular risk factors,
the distribution among the three groups showed fewer
males in the open HR group (85.8%; p < 0.01; df 2) and less
dyslipidaemia in the EVAR HR group (46.6%, p < 0.01; df 2).
Approximately half of patients (range 43e52%) in each
group presented with three or more cardiovascular risk
factors. Regarding past medical history, there were signif-
icantly more cancers (23.6%, p < 0.01, df 2) and cardiac
disease (67.5%, p < 0.01, df 2) in the EVAR HR group. The
distribution of high-risk criteria was similar in both high-risk
groups (EVAR HR and open HR), except for a higher number
of patients above 80 years of age (54.5%, p < 0.01, df 1) in
the open HR group, and significantly more previous heartfailure (29.1%, p < 0.01; df 1) and hostile abdomen (25.6%,
p < 0.01, df 1), in the endovascular group (EVAR HR). A
significant difference in the presence of AFSSAPS criteria
was noted between the EVAR HR and open HR group
(p < 0.01, df 3).While more patients with a single AFSSAPS
high-risk factor presented in the open HR (81 versus 57%),
more patients with two (32 versus 16%) and three risk
factors (10 versus 3%) were noted in the EVAR HR group. No
difference was noted in the small number of patients with
four or more AFSSAPS risk factors. The operative data
presented in Table 2 show that the EVAR HR patients had
a significantly lower intraoperative blood loss (311 ml,
p < 0.01, df 2) and a shorter operation time (146 min,
p < 0.01, df 2), mean intensive care unit stay (1  3 days,
95% confidence interval (CI) 0e1 p < 0.01, df 2) and mean
hospitalisation (8  7 days, 95% CI 7e9 days, p < 0.01, df
2), compared with the two open repair groups. There was
no significant difference between the two open repair
groups with regard to operative data. The postoperative
complications were analysed and are presented with the
causes of death in Table 3. No significant difference was
noticed among the groups, despite a relatively high
mortality rate of 5.4% in the EVAR HR group, which will be
discussed later.
The KaplaneMeier analysis highlighted the fact that
open repair low-risk patients showed a significantly higher
60-month cumulative survival of 84% than did the high-risk
EVAR HR (59%; p < 0.001) or high-risk open repair patients
(70%; pZ 0.002), with no significant difference between
the two latter groups (pZ 0.252).
Fig. 2 shows the MCAs14 that were used to jointly
examine the relationship between high-risk criteria and
mortality at different time points. Renal insufficiency
seemed to correlate with early mortality (postoperative, at
12 and 24 months). ‘Age over 80’ appeared to correlate
with late mortality (at 48 and 60 months).
Discussion
The first aim of our study was to compare the postoperative
mortality rate among the three groups, and surprisingly,
there was no statistical difference. The mortality rate for
Table 3 Details of postoperative complications death. HR: high-risk; LR: low-risk.
Population: N (%) EVAR HR Open HR Open LR
148 (24%) 134 (21%) 344 (55%)
N (%) N (%) N (%)
a. Postoperative complications: pZ 0.273z dfZ 2
Patients with complications (N and %) 44 (29.7) 50 (37.3) 119 (34.6)
/ Details of postoperative complications N (% of l)
Cardiac 2 (5) 15 (30) 24 (20)
Wound 12 (27) 16 (32) 18 (15)
Digestive 2 (5) 8 (16) 8 (7)
Neurologic 2 (5) 2 (4) 2 (2)
Prosthesis 4 (9) 3 (6) 4 (3)
Pulmonary 5 (11) 20 (40) 29 (24)
Renal 9 (20) 11 (22) 29 (24)
Urinary 2 (5) 2 (4) 1 (1)
Vascular 22 (50) 35 (70) 44 (37)
Total complications (n) 60 112 159
Complications per patient 1. 4 2.2 1.3
b. Causes of postoperative death: pZ 0.242z dfZ 2
Number of deaths (% in each group) 8 (5.4) 5 (3.7) 8 (2.3)
/ Details of postoperative cause of death
Myocardial infarction (n) 3 0 1
Intestinal ischemia (n) 1 3 4
Sepsis (n) 1 1 2
Pulmonary embolism (n) 0 0 1
Multiple organ failure (n) 3 1 0
Total (n) 8 5 8
z Fisher’s Exact test.
High-risk Criteria Selection in AAA Treatment 407EVAR of 5.4% in our series is clearly one of the highest rates
reported in this setting, ranging from 0 to 5.3%.15e20 The
causes of death are presented in Table 3. Four patients out
of eight presented an acute ischaemic event (three
myocardial infarctions and one intestinal infarction), which
may be explained by our former policy of stopping anti-
platelet drugs 1 week before any type of operation. After
2003, we decided to maintain anti-platelet drugs, and
thereafter, no other postoperative ischaemic events have
occurred. Although the 30-day mortality rate in the EVAR
HR group (5.4%) was high, the difference between the
groups was not significant. Surprisingly, in the open HR
group the mortality rate was low at 3.7%. According to the
AFSSAPS criteria, these patients were considered high-risk
as they were supposedly unfit for open surgery. The post-
operative course showed that these patients were in fact
good candidates for open surgery, even though they pre-
sented with high-risk criteria.
A major limit of this study is the way the groups were
formed. As we followed the AFSSAPS recommendations, no
low-risk patients received EVAR. The open HR group con-
tained patients with AAAs that were morphologically
different: some aortas were unsuitable for endografting,
while others were favourably shaped, but in patients who
were unwilling to be treated with an endovascular graft, or
for whom the referring surgeon did not recommend endo-
vascular treatment. However, the series was continuous
and reflected real-life clinical practice in a vascular
department in a French teaching hospital. The three groupswere comparable in term of hypertension, smoking, dia-
betes mellitus, number of cardiovascular risk factors per
patient, rate of peripheral arterial occlusive disease,
history of stroke and transient ischaemic attack.
Regarding the distribution of AFSSAPS high-risk criteria,
the number of octogenarians was even higher in open HR
group, which emphasises the fact that age does not neces-
sarily reflect the stateof thearteries. As previously reported,
age should not be a critical criterion when deciding whether
or not to repair an AAA.21 Conversely, octogenarians seem to
have higher life expectancy after AAA repair, as showed in
Fig. 2, (green zone, dotted lines); plots correspond to death
rates at 48 and 60 months. This surprising finding is in keeping
with the publication ofMani et al., who recently reported the
long-term outcomes from the Swedish Vascular Registry and
showed that relative 5-year survival after elective AAA repair
was better for octogenarians than for patients <80 years of
age.22 Another remarkable difference between the two high-
risk groups concerns the rate of heart failure and hostile
abdomen in the EVAR HR group, which was significantly
higher than in the open HR group. Both these conditions
discourage the surgeon from proposing open repair to
patients, even though these conditions do not correlate with
early death after surgery as shown in Fig. 2. Renal insuffi-
ciency, however, does correlate with a high rate of post-
operative complications and early death (postoperative, at
12 and 24 months) as shown in Fig. 2 (red zone, dashed lines)
and has to be considered a high-risk factor regardless of the
type of AAA treatment.
Figure 1 KaplaneMeier survival analysis of the EVAR high-risk (green), open repair high-risk (pink) and open repair low-risk (blue)
groups. The Log-Rank test includes the curves only until 60 months. The further curves until 84 months are for information only, as
the number of patients at risk was less than 20% of the original population at 72 months already. The 95% CI is indicated by
horizontal bars every 12 months. The standard error did not exceed 10% until 84 months (SE maxZ 6.3%) in all three groups.
Figure 2 Multiple correspondence analysis (MCA); the original variables are represented in a space defined by factorial axes,
which are characterized by a percentage of inertia (i.e. the amount of total variability explained by the axis itself). The distance
between points indicates the dissimilarities between categories, while categories that plot close to each other are statistically
related and are similar with regard to the pattern of relative frequencies.12 COPD, chronic obstructive pulmonary disease.
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High-risk Criteria Selection in AAA Treatment 409Though our series is neither prospective nor randomised,
the findings contrast with the results of the ‘EVAR 2’ trial,23
but match results in other published series that included
high-risk patients.18,19 Nevertheless, the high-risk popu-
lation analysed in this series had a lower life expectancy
compared to low-risk patients. We did not assess here the
quality of life and the potential drawbacks of the life-long
follow-up required by endovascular repair.
The ideal candidates for endovascular repair are still to
be defined. Data from the EVAR trials suggest that the
healthiest patients are the ones most likely to benefit from
the procedure, and that they are also the most likely to
tolerate open surgical procedures with acceptable rates of
postoperative complications and death.24
Conclusion
In our single-centre continuous series, the high-risk
criteria as defined by the French health agency AFSSAPS
predicted neither complications nor postoperative
mortality. They cannot be decisive in the choice of treat-
ment. The sum of these risks, however, seems to be
predictive of complications or mortality, but gives no
indication of the type of treatment that is most likely to be
successful for a given patient. Each high-risk criterion
should be weighted independently to assess its relevance
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